HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2-chloro-5-nitrobenzanilide

pretreatment of peroxisome proliferator activated receptors with GW9662 results in the irreversible loss of ligand binding
Also Known As:
GW9662
Networked: 88 relevant articles (6 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Thiemermann, Christoph: 4 articles (01/2007 - 12/2004)
2. Collin, Marika: 4 articles (01/2007 - 12/2004)
3. Kopelovich, Levy: 3 articles (01/2013 - 03/2012)
4. Linnebacher, Michael: 2 articles (11/2013 - 01/2013)
5. Hinz, Burkhard: 2 articles (11/2013 - 01/2013)
6. Ramer, Robert: 2 articles (11/2013 - 01/2013)
7. Wang, Hao: 2 articles (01/2013 - 11/2011)
8. Ye, Ping: 2 articles (01/2013 - 11/2011)
9. Mogi, Masaki: 2 articles (01/2012 - 08/2010)
10. Iwanami, Jun: 2 articles (01/2012 - 08/2010)

Related Diseases

1. Vascular System Injuries
2. Inflammation
3. Endotoxemia
4. Insulin Resistance
5. Hyperalgesia

Related Drugs and Biologics

1. telmisartan (Micardis)
2. Losartan (Cozaar)
3. PPAR gamma
4. Peroxisome Proliferator-Activated Receptors (PPAR)
5. T 0070907
6. pioglitazone (Actos)
7. Cytokines
8. Metyrapone
9. Insulin (Novolin)
10. Indomethacin (Indometacin)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Aftercare (After-Treatment)
3. Oral Administration